Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted April 25, 2022
Some OTC Skin Lighteners Contain Potentially Harmful Ingredient, Warns FDA
On April 19th, 2022, the FDA issued warnings to 12 companies for selling over-the-counter (OTC) skin-lightening products containing hydroquinone.
Hydroquinone is an active ingredient in Tri-Luma, an FDA approved prescription product approved for the short-term treatment of dark spots associated with moderate-to-severe melasma of the face. However, serious side effects, including skin rash, facial swelling, and discoloration of the skin, which can be permanent, have been reported with the use of this drug, and it should only be used under physician supervision. The FDA has not approved any over-the-counter products containing hydroquinone or any other ingredient for the purpose of skin lightening.
For more details, use the links below to read the full warning letter issued to each company:
- AMBI Enterprises LLC (AMBI Skincare Fade Cream Oily Skin and AMBI Skincare Fade Cream Normal Skin)
- Clinical Formula LLC (Clinical Formula Bleaching Lotion)
- Dr. Thomas Balshi/Intilight (Intilight Intimate Lightening Treatment)
- Elements Brands Inc. (eb5 Skin Lightening Cream)
- Genomma Lab USA, Inc. (cicatricure Medical Lightening Skin Lightening Cream and teatrical Pro-Aclarant Skin Lightening Night Cream)
- M & M Beauty and Wellness, LLC (Best age spot remover lightening perfection crème)
- Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc. (Alpha Skin Care Dual Action Fade Cream)
- Skin Authority, L.L.C. (skinauthority Hyperpigmentation Treatment)
- SkinPro (SkinPro Ultra Brightener Hydroquinone)
- Skin PS Brands (Dark Spot Fix)
- True Earth Health Products, LLC (Plexaderm Skincare Dark Spot Fade Gel)
- Ultimark Products (Porcelana Day Skin Lightening Cream)
The agency has advised that each company respond within 15 days of receipt of the warning, outlining any steps taken to correct violations.
Health care professionals and consumers who wish to report adverse reactions or quality problems experienced with the use of these products may do so through the FDA’s MedWatch Adverse Event Reporting.
For more information about skin lightening ingredients, see ConsumerLab’s answer to the question: Do glutathione supplements work to prevent aging or for other conditions?
Also see our article about safe and effective sunscreens.
For more information, use the link below.
FDA works to protect consumers from potentially harmful OTC skin lightening products
See related recalls and warnings:
FDA Warns Consumers Not to Use Dangerous Black Salve Products
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
